Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 2, 2003, Pages 337-341

  Singh, Anurag K ^a   Lockett, Mary Ann ^a   Bradley, Jeffrey D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conformal radiotherapy; Esophagitis; Non small cell lung cancer

Indexed keywords

CHEMOTHERAPY; ONCOLOGY; TOXICITY; TUMORS;

SUBCARINAL NODES;

RADIOTHERAPY;

CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; NAVELBINE; PACLITAXEL; TOPOTECAN; VINBLASTINE SULFATE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE SEVERITY; DOSIMETRY; ESOPHAGITIS; FEMALE; GENDER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERFORMANCE; PRIORITY JOURNAL; RACE; RADIATION DOSE; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; ESOPHAGEAL DISEASES; ESOPHAGITIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 0037298098     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03937-8     Document Type: Article

References (10)

1. Choy H., Akerley W., Graziano S. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol. 16:1998;3316-3322.
2. Werner-Wasik M., Scott C., Graham M.V. Interfraction interval dose not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy A multivariate analysis of 1076 RTOG patients . Int J Radiat Oncol Biol Phys. 44:1999;327-331.
3. Bradley J.D., Ieumwananonthachai N., Purdy J.A., et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys. 52:2002;49-57.
4. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
5. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small cell lung cancer. N Engl J Med. 323:1990;940-945.
6. Sause W., Kolesar P., Taylor S., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group . Chest. 117:2000;358-364.
7. Boal D.K.B., Newburger P.E., Teele R.L. Esophagitis induced by combined radiation and adriamycin. Am J Radiol. 137:1979;567-570.
8. Umsawasdi T., Valdivieso M., Barkley H.T. Jr. Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 11:1985;511-519.
9. Werner-Wasik M., Pequignot E., Leeper D. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of the irradiated esophagus A multivariate analysis of patients with lung cancer treated with nonoperative therapy . Int J Radiat Oncol Biol Phys. 48:2000;689-696.
10. Maguire P.D., Sibley G.S., Zhou S.M., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys. 45:1999;97-103.